Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé

S. Ladoire; F. Ghiringhelli; P. Manckoundia; R. O. Casasnovas; E. Solary; J. F. Besancenot; P. Pfitzenmeyer

doi:10.1016/j.revmed.2004.09.010

Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé

Translated title of the contribution: Treatment of cancer and hematological malignancy in elderly people (Part II)

S. Ladoire, F. Ghiringhelli, P. Manckoundia, R. O. Casasnovas, E. Solary, J. F. Besancenot, P. Pfitzenmeyer

Research output: Contribution to journal › Short survey › peer-review

1 Citation (Scopus)

Abstract

Purpose. - Fifty percents of cancer arise in people older than 65-year-old. Most clinical trials in cancer treatment are limited in patients younger than 65-year-old. We review literature-describing particularity of cancer treatment in elderly patients. Current knowledge and key points. - Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients. Future prospects and projects. - We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.

Translated title of the contribution	Treatment of cancer and hematological malignancy in elderly people (Part II)
Original language	French
Pages (from-to)	304-314
Number of pages	11
Journal	Revue de Medecine Interne
Volume	26
Issue number	4
DOIs	https://doi.org/10.1016/j.revmed.2004.09.010
Publication status	Published - 1 Jan 2005
Externally published	Yes

Access to Document

10.1016/j.revmed.2004.09.010

Cite this

Ladoire, S., Ghiringhelli, F., Manckoundia, P., Casasnovas, R. O., Solary, E., Besancenot, J. F., & Pfitzenmeyer, P. (2005). Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé. Revue de Medecine Interne, 26(4), 304-314. https://doi.org/10.1016/j.revmed.2004.09.010

@article{9ec6d1835ae047948f6d02b7d3b5ce3e,

title = "Prise en charge des cancers solides et des h{\'e}mopathies malignes du sujet {\`a}g{\'e}: l'Oncog{\'e}riatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des h{\'e}mopathies malignes du sujet {\`a}g{\'e}",

abstract = "Purpose. - Fifty percents of cancer arise in people older than 65-year-old. Most clinical trials in cancer treatment are limited in patients younger than 65-year-old. We review literature-describing particularity of cancer treatment in elderly patients. Current knowledge and key points. - Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients. Future prospects and projects. - We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.",

keywords = "Cancer, Elderly patients, Treatment",

author = "S. Ladoire and F. Ghiringhelli and P. Manckoundia and Casasnovas, {R. O.} and E. Solary and Besancenot, {J. F.} and P. Pfitzenmeyer",

year = "2005",

month = jan,

day = "1",

doi = "10.1016/j.revmed.2004.09.010",

language = "Fran{\c c}ais",

volume = "26",

pages = "304--314",

journal = "Revue de Medecine Interne",

issn = "0248-8663",

number = "4",

}

Ladoire, S, Ghiringhelli, F, Manckoundia, P, Casasnovas, RO, Solary, E, Besancenot, JF & Pfitzenmeyer, P 2005, 'Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé', Revue de Medecine Interne, vol. 26, no. 4, pp. 304-314. https://doi.org/10.1016/j.revmed.2004.09.010

Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé. / Ladoire, S.; Ghiringhelli, F.; Manckoundia, P. et al.
In: Revue de Medecine Interne, Vol. 26, No. 4, 01.01.2005, p. 304-314.

Research output: Contribution to journal › Short survey › peer-review

TY - JOUR

T1 - Prise en charge des cancers solides et des hémopathies malignes du sujet àgé

T2 - l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé

AU - Ladoire, S.

AU - Ghiringhelli, F.

AU - Manckoundia, P.

AU - Casasnovas, R. O.

AU - Solary, E.

AU - Besancenot, J. F.

AU - Pfitzenmeyer, P.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Purpose. - Fifty percents of cancer arise in people older than 65-year-old. Most clinical trials in cancer treatment are limited in patients younger than 65-year-old. We review literature-describing particularity of cancer treatment in elderly patients. Current knowledge and key points. - Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients. Future prospects and projects. - We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.

AB - Purpose. - Fifty percents of cancer arise in people older than 65-year-old. Most clinical trials in cancer treatment are limited in patients younger than 65-year-old. We review literature-describing particularity of cancer treatment in elderly patients. Current knowledge and key points. - Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients. Future prospects and projects. - We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.

KW - Cancer

KW - Elderly patients

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=17044403850&partnerID=8YFLogxK

U2 - 10.1016/j.revmed.2004.09.010

DO - 10.1016/j.revmed.2004.09.010

M3 - Brève enquête

C2 - 15820566

AN - SCOPUS:17044403850

SN - 0248-8663

VL - 26

SP - 304

EP - 314

JO - Revue de Medecine Interne

JF - Revue de Medecine Interne

IS - 4

ER -

Ladoire S, Ghiringhelli F, Manckoundia P, Casasnovas RO, Solary E, Besancenot JF et al. Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé. Revue de Medecine Interne. 2005 Jan 1;26(4):304-314. doi: 10.1016/j.revmed.2004.09.010

Prise en charge des cancers solides et des hémopathies malignes du sujet àgé: l'Oncogériatrie, une discipline en devenir. Seconde partie: Traitement des cancers solides (partie 2) et des hémopathies malignes du sujet àgé

Abstract

Access to Document

Other files and links

Cite this